Dental Anesthesia Market

Global Dental Anesthesia Market Size, Share & Trends Analysis Report, By Product Type (Bupivacaine, Mepivacaine, Lidocaine, and Prilocaine), By Type (Local Anesthesia and General Anesthesia), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025345 | Category : Pharmaceuticals | Delivery Format: /

The global dental anesthesia market is expected to grow at a significant CAGR during the forecast period (2021-2027). Investments in sophisticated anesthesia administration tools and dental research have been increasing significantly. The growing dental population base and the growing inclination towards dental health checkups are all factors boosting the market growth. The market is predicted to grow as the elderly population grows and new products are introduced. The market is projected to be restrained by government regulations, ignorance of oral diseases, and the use of traditional therapies.

Gingivitis, periodontitis, and oral cancer incidences are predicted to rise, resulting in a rise in dental procedures and, as a result, a rise in the need for dental anesthesia globally. Increased tobacco and cigarette usage, as well as changes in dietary habits, are likely to increase dental and other oral and maxillofacial problems. During the forecast period, the rising prevalence of dental problems will fuel the growth of the dental anesthesia market. Poor oral health may have a profound effect on general health, and several oral diseases are related to chronic diseases such as diabetes. Painful experiences and various problems associated with chewing, eating, smiling and communication due to missing, damaged or discolored teeth account for a major impact on people's daily lives and well-being. Apart from that, oral diseases restrict activities at school, at work, and at home causing millions of school and work hours to be lost each year throughout the world.

Periodontal disease and tooth decay have been considered the most important global oral health burdens. As per the Centers for Disease Control and Prevention (CDC) in 2015, about half of the US population, aged 30 years or more have periodontitis which is considered as the more advanced form of periodontal disease. Moreover, around 64.7 million US citizens accounted for this disease in 2016. Chronic periodontitis is another most advanced form of the disease which progresses relatively slowly in most people and is found typically more evident in adulthood. Some major risk factors include smoking, inherited or genetic susceptibility, and lack of adequate home care, age, diet, health history, and medications. 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: Johnson & Johnson Services, Inc., Astra Zeneca plc, Septodont, Dentsply Sirona Inc., and Gilead Sciences Inc., among others. 

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Dental Anesthesia Market Report Segmentation

By Product Type

Bupivacaine

Mepivacaine

Lidocaine

Prilocaine

By Type 

Local Anesthesia

General Anesthesia

Global Dental Anesthesia Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific